全基因组表达筛查揭示参与甲状腺癌发生的长链非编码RNA
研究对12对甲状腺乳头状癌(PTC)肿瘤及配对非癌组织行RNA测序,鉴定出218个差异表达lncRNA(倍数变化≥2.0,P<.01)。其中XLOC_051122和XLOC_006074的表达与淋巴结转移(N分期)及BRAF(V600E)突变显著相关,在BRAF野生型患者中伴淋巴结转移者表达更高。作者认为这2个lncRNA可能是PTC发生的新参与者。
要点
- RNA测序12对PTC组织鉴定出218个差异表达lncRNA。
- XLOC_051122和XLOC_006074表达与N分期及BRAF(V600E)相关。
- BRAF野生型患者中伴淋巴结转移者这2个lncRNA表达更高。
核心结论
- 全基因组表达筛查鉴定出2个与PTC患者不良预后风险因素相关的新lncRNA,可能是PTC发生的新参与者。
研究设计与样本
- 对12对PTC肿瘤及配对非癌组织行RNA测序并将lncRNA表达与临床参数关联。
- 在俄亥俄PTC队列(n=109)及癌症基因组图谱PTC数据(n=497)中研究2个最显著失调的lncRNA。
- 研究结合实验室工作与利用临床数据、样本及公开数据库的计算分析。
主要发现
- 共鉴定出218个在PTC中差异表达的lncRNA(倍数变化≥2.0,P<.01)。
- XLOC_051122和XLOC_006074的表达与淋巴结转移(N分期)及BRAF(V600E)突变显著相关。
- 在BRAF野生型患者中,伴淋巴结转移者的这2个lncRNA表达水平显著更高。
- 对上述lncRNA的计算机分析提示细胞运动和细胞生长与增殖为其靶向功能。
关键数值与推荐
- 差异表达标准为倍数变化≥2.0且P<.01。
- XLOC_051122和XLOC_006074的表达与N分期及BRAF(V600E)突变显著相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Long noncoding RNAs (lncRNAs) regulate pathological processes, yet their potential roles in papillary thyroid carcinoma (PTC) are poorly understood. OBJECTIVE: To profile transcriptionally dysregulated lncRNAs in PTC and identify lncRNAs associated with clinicopathological characteristics. DESIGN: We performed RNA sequencing of 12 paired PTC tumors and matched noncancerous tissues and correlated the expression of lncRNAs with clinical parameters. The 2 most significantly dysregulated lncRNAs were studied in an Ohio PTC cohort (n = 109) and in PTC data (n = 497) from The Cancer Genome Atlas. SETTING: A combination of laboratory-based studies and computational analysis using clinical data and samples and a publically available database. MAIN OUTCOME MEASURES: Correlation between expression values and clinical parameters. RESULTS: We identified 218 lncRNAs showing differential expression in PTC (fold change ≥ 2.0, P < .01). Significant correlation was observed between the expression of 2 lncRNAs (XLOC_051122 and XLOC_006074) and 1) lymph node metastasis (N stage) and 2) BRAF(V600E) mutation. Among patients with wild-type BRAF, the expression of these 2 lncRNAs showed significantly higher levels in the patients with lymph node metastasis. In silico analysis of these lncRNAs pinpointed cell movement and cellular growth and proliferation as targeted functions. CONCLUSIONS: Comprehensive expression screening identified 2 novel lncRNAs associated with risk factors of adverse prognosis in PTC patients. These lncRNAs may be novel players in PTC carcinogenesis.
引用
- Liyanarachchi S, Li W, Yan P, et al. Genome-Wide Expression Screening Discloses Long Noncoding RNAs Involved in Thyroid Carcinogenesis. J Clin Endocrinol Metab. 2016. PMID: 27459529
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。